Although these studies provided a strong support for a role of EGF genetic polymorphism in the progression of liver disease from fibrosis/cirrhosis to malignant stage, these data provide no information on the relationship between EGF genetic polymorphism and risk of HCC in a general population as discussed by Galmozzi and Colombo [32]. This evidence concerns the gene EGF and hepatocellular carcinoma.